Table 4.
Treatments and responses by cancer stage groupings stages I-IIA and stages IIB-IV
| Response Evaluation | Stage I-IIA (N = 71) | Stage IIB-IV (N = 64) | Total (N = 135) | P value |
|---|---|---|---|---|
| Time to response (at first evaluation) | .467* | |||
| Mean (SD) | 57.6 (40.4) | 51.0 (58.2) | 54.7 (49.0) | |
| Median (Q1, Q3) | 46.0 (31.0, 79.0) | 39.5 (18.0, 56.2) | 43.0 (23.0, 70.0) | |
| Range | 1.0-173.0 | 6.0-385.0 | 1.0-385.0 | |
| Missing | 6 | 12 | 18 | |
| Type of response (at first evaluation) | .569† | |||
| Complete response | 25 (35.2%) | 19 (29.7%) | 44 (32.6%) | |
| Near complete response | 20 (28.2%) | 14 (21.9%) | 34 (25.2%) | |
| No response | 6 (8.5%) | 8 (12.5%) | 14 (10.4%) | |
| Partial response | 20 (28.2%) | 23 (35.9%) | 43 (31.9%) | |
| Time to progression | .171* | |||
| Mean (SD) | 195.1 (168.0) | 144.4 (145.0) | 173.1 (159.4) | |
| Median (Q1, Q3) | 130.0 (87.5, 259.5) | 76.0 (58.0, 189.0) | 107.5 (67.8, 233.5) | |
| Range | 1.0-734.0 | 13.0-524.0 | 1.0-734.0 |
⁎
Linear model analysis of variance.
†
Pearson's χ2 test.